4.7 Article

Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: An update on current advances and impediments

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Individual susceptibility has a major impact on strong association between oxidative stress, defence systems and Parkinson's disease

Bensu Karahalil et al.

Summary: Oxidative stress is important in the degeneration of dopaminergic neurons in Parkinson's disease. Individual susceptibility may be associated with the development of oxidative stress-based PD, and measuring oxidative stress-related biomarkers can help manage the detrimental effects of the disease.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2022)

Review Behavioral Sciences

The interplay between oxidative stress and autophagy: focus on the development of neurological diseases

Marjan Talebi et al.

Summary: This review provides an overview of the interaction between autophagy and oxidative stress in neurological diseases, and discusses the underlying molecular mechanisms. Novel treatments for neurological disorders can be developed by targeting this interaction.

BEHAVIORAL AND BRAIN FUNCTIONS (2022)

Article Biochemistry & Molecular Biology

Polygala saponins inhibit NLRP3 inflammasome-mediated neuroinflammation via SHP-2-Mediated mitophagy

Wen-Qiao Qiu et al.

Summary: This study demonstrates that triterpenoid saponins in Radix Polygalae inhibit the activation of the NLRP3 inflammasome via SHP-2-mediated mitophagy, suggesting therapeutic potential in neurodegenerative diseases.

FREE RADICAL BIOLOGY AND MEDICINE (2022)

Review Biochemistry & Molecular Biology

Impact of ER Stress and ER-Mitochondrial Crosstalk in Huntington's Disease

Shuvadeep Maity et al.

Summary: Accumulation of misfolded proteins is common in neurodegenerative diseases, particularly those caused by abnormal PolyQ expansions. The disruption of protein homeostasis in the endoplasmic reticulum (ER) and activation of the unfolded protein response (UPR) pathway are linked to the development of Huntington's disease (HD). Furthermore, proteins at ER-mitochondria contact sites (MAMs) play a significant role in HD progression. This review provides updated information on UPR pathways and their involvement in HD, as well as the role of MAMs in disease progression. Therapeutic interventions focusing on ER stress response proteins and ER-mitochondrial contact proteins are discussed.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Mast cells and histamine are involved in the neuronal damage observed in a quinolinic acid-induced model of Huntington's disease

Pablo Eliasib Martinez-Gopar et al.

Summary: The study shows that mast cells (MCs) and histamine (HA) play a role in the neuronal and oxidative damage observed in mice subjected to the QUIN-induced model of Huntington's disease.

JOURNAL OF NEUROCHEMISTRY (2022)

Article Neurosciences

Pharmacological Modulation of TRPM2 Channels via PARP Pathway Leads to Neuroprotection in MPTP-induced Parkinson's Disease in Sprague Dawley Rats

Bhupesh Vaidya et al.

Summary: This study investigated the role of TRPM2 channels in the MPTP-induced PD rat model and found that the TRPM2 inhibitor 2-APB and PARP inhibitor PJ-34 improved locomotor and cognitive deficits in PD rats and reduced oxidative stress levels. These results provide a rationale for the development of drugs targeting the TRPM2-PARP pathway.

MOLECULAR NEUROBIOLOGY (2022)

Article Neurosciences

Recent Advances in Molecular Pathways and Therapeutic Implications Targeting Mitochondrial Dysfunction for Alzheimer's Disease

Rishika Dhapola et al.

Summary: Alzheimer's disease is a neurodegenerative disorder caused by mitochondrial dysfunction, with drugs targeting mitochondria in clinical trials. Modulation of mitochondrial dynamics and reduction of ROS production are potential therapeutic strategies.

MOLECULAR NEUROBIOLOGY (2022)

Review Cell Biology

Deciphering the role of PGC-1α in neurological disorders: from mitochondrial dysfunction to synaptic failure

Jessica D. Panes et al.

Summary: This review provides an up-to-date overview of the role of PGC-1α in the physiopathology of neurodegenerative diseases and establishes its importance in synaptic transmission and neuronal survival.

NEURAL REGENERATION RESEARCH (2022)

Article Biochemistry & Molecular Biology

Pioglitazone transiently stimulates paraoxonase-2 expression in male nonhuman primate brain: Implications for sex-specific therapeutics in neurodegenerative disorders

Jennifer K. Blackburn et al.

Summary: PON2 enhances mitochondria function and protects against oxidative stress, while pioglitazone transiently increases PON2 expression in the brain. This short-term impact may contribute to the differences observed between short-term animal models and clinical trials for Parkinson's disease.

NEUROCHEMISTRY INTERNATIONAL (2022)

Article Biochemistry & Molecular Biology

Urolithin A protects dopaminergic neurons in experimental models of Parkinson's disease by promoting mitochondrial biogenesis through the SIRT1/PGC-1α signaling pathway

Jia Liu et al.

Summary: UA, a gut metabolite produced from ellagic acid-containing foods, shows potential protective effects against PD by promoting mitochondrial biogenesis and preventing neurotoxicity induced by 6-OHDA. This study provides new insights into the role of UA in regulating mitochondrial dysfunction in PD and suggests potential therapeutic applications.

FOOD & FUNCTION (2022)

Review Cell Biology

Interaction of Mitochondrial Calcium and ROS in Neurodegeneration

Artyom Y. Baev et al.

Summary: Neurodegenerative disorders are devastating diseases characterized by the loss of neurons in specific brain regions. Recent research has identified genes, toxins, and risk factors associated with these diseases, and has found similarities in the involvement of mitochondria, oxidative stress, and abnormal calcium signaling in neurons and astrocytes.
Article Engineering, Biomedical

Amelioration of Alzheimer's disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow

Chenglong Xie et al.

Summary: This study utilized machine learning and a cross-species approach to identify and validate two potent mitophagy inducers. These compounds improved neuronal survival and functionality, abrogated pathology in AD models, and enhanced memory.

NATURE BIOMEDICAL ENGINEERING (2022)

Article Biochemistry & Molecular Biology

Gene therapy of yeast NDI1 on mitochondrial complex I dysfunction in rotenone-induced Parkinson's disease models in vitro and vivo

Hongzhi Li et al.

Summary: This study investigates whether yeast internal NADH-quinone oxidoreductase (NDI1) can replace defective mammalian mitochondrial complex I in the treatment of Parkinson's disease caused by mitochondrial complex I dysfunction. The results show that NDI1 can rescue the defect in oxidative phosphorylation in PD cell and mouse models, and ameliorate neurobehavioral and neuropathological damages.

MOLECULAR MEDICINE (2022)

Review Neurosciences

Solving neurodegeneration: common mechanisms and strategies for new treatments

Lauren K. Wareham et al.

Summary: There may be common mechanisms across neurodegenerative diseases that can lead to new therapeutic targets. A virtual meeting was organized to discuss these mechanisms and emerging treatments. The meeting focused on neuroinflammation, bioenergetics and metabolism, genetic contributions, and neurovascular interactions as major areas of mechanistic overlap.

MOLECULAR NEURODEGENERATION (2022)

Review Neurosciences

LRRK2 and idiopathic Parkinson's disease

Emily M. Rocha et al.

Summary: The etiology of idiopathic Parkinson's disease involves multiple factors, including genetics and environmental exposures. LRRK2 plays an important role in iPD, regardless of mutations, by influencing kinase activation and substrate phosphorylation, which contribute to the pathogenesis.

TRENDS IN NEUROSCIENCES (2022)

Article Biochemistry & Molecular Biology

Hyperbaric Oxygen Therapy Improves Parkinson's Disease by Promoting Mitochondrial Biogenesis via the SIRT-1/PGC-1α Pathway

Hung-Te Hsu et al.

Summary: The study suggests that hyperbaric oxygen therapy may have potential protective effects against Parkinson's disease by promoting mitochondrial biogenesis, reducing apoptotic signaling, and attenuating inflammatory mediators.

BIOMOLECULES (2022)

Editorial Material Biochemistry & Molecular Biology

Oxidative Stress in Neurodegenerative Diseases

Andrii Domanskyi et al.

ANTIOXIDANTS (2022)

Article Chemistry, Medicinal

Unveiling the Multitarget Anti-Alzheimer Drug Discovery Landscape: A Bibliometric Analysis

Anna Sampietro et al.

Summary: Research on multitarget anti-Alzheimer agents has seen a rapid increase in publications, with China, Italy, and Spain being the leading countries in this field. The scopolamine-induced amnesia mouse model is commonly used in in vivo studies, and there are variations in research trends among different countries.

PHARMACEUTICALS (2022)

Article Biology

Failure of DNA double-strand break repair by tau mediates Alzheimer's disease pathology in vitro

Megumi Asada-Utsugi et al.

Summary: Phosphorylated tau protein accumulates at DNA double-strand breaks (DSBs) in neurons, and failure of DSB repair leads to increased tau pathology, potentially associated with Alzheimer's disease.

COMMUNICATIONS BIOLOGY (2022)

Article Neurosciences

Progressive Mitochondrial Dysfunction of Striatal Synapses in R6/2 Mouse Model of Huntington's Disease

Maria Hvidberg Petersen et al.

Summary: This study reveals that synaptic mitochondria in the striatum are more severely affected by Huntington's disease pathology than those in the cortex, leading to increased oxygen consumption and mitochondrial proton leak of striatal synaptosomes.

JOURNAL OF HUNTINGTONS DISEASE (2022)

Review Cell Biology

Neuroinflammation as a mechanism linking hypertension with the increased risk of Alzheimer's disease

Ekta Bajwa et al.

Summary: Alzheimer's disease, the most common type of dementia among older adults, currently cannot be prevented or effectively treated. Persistent midlife hypertension is a modifiable risk factor that can be effectively controlled through changes in diet, lifestyle, and antihypertensive drugs.

NEURAL REGENERATION RESEARCH (2022)

Article Biotechnology & Applied Microbiology

Balanced mitochondrial and cytosolic translatomes underlie the biogenesis of human respiratory complexes

Iliana Soto et al.

Summary: This study shows that human OXPHOS complexes are synthesized proportionally to each other, and the balance between mitochondrial and nuclear genes relies on the regulation of OXPHOS subunit translation across cellular compartments.

GENOME BIOLOGY (2022)

Article Cell Biology

Mutant HTT (huntingtin) impairs mitophagy in a cellular model of Huntington disease

Sandra Franco-Iborra et al.

Summary: The study found that HTT protein plays a crucial role in mitophagy, and the expansion of its polyQ tract affects this process, ultimately leading to the accumulation of damaged mitochondria and an increase in oxidative stress, leading to negative effects on mitochondrial dysfunction and neurodegeneration in Huntington disease.

AUTOPHAGY (2021)

Review Neurosciences

Update on the association between alpha-synuclein and tau with mitochondrial dysfunction: Implications for Parkinson's disease

Si-Tong Feng et al.

Summary: The review highlights the critical role of mitochondrial dysfunction in Parkinson's disease, with various Parkinson's proteins being associated with this dysfunction and oxidative stress. The interaction between alpha-synuclein and tau proteins amplifies neurotoxic effects on mitochondria, while oxidative stress caused by dysfunction favors the formation of protein aggregates and plays a key role in PD progression.

EUROPEAN JOURNAL OF NEUROSCIENCE (2021)

Review Chemistry, Medicinal

Activation of transcription factor Nrf2 to counteract mitochondrial dysfunction in Parkinson's disease

Claudia Bento-Pereira et al.

Summary: Parkinson's disease is a progressive neurodegenerative disorder for which no disease-modifying therapies are available. Factors like age, genetic predisposition, and environmental stressors are known to increase the risk of developing PD. Activation of Nrf2 has shown to be beneficial in cellular and animal models of PD.

MEDICINAL RESEARCH REVIEWS (2021)

Article Biochemistry & Molecular Biology

NRF2 activation by reversible KEAP1 binding induces the antioxidant response in primary neurons and astrocytes of a Huntington's disease mouse model

Daniele Moretti et al.

Summary: Oxidative stress is associated with various diseases, and activation of NRF2 by a small-molecule drug may help control oxidative stress. This study validated a reversible non-acidic KEAP1 binder for NRF2 activation with lower off-target effects.

FREE RADICAL BIOLOGY AND MEDICINE (2021)

Article Biochemical Research Methods

Baicalein Mediates Mitochondrial Autophagy via miR-30b and the NIX/BNIP3 Signaling Pathway in Parkinson's Disease

Min Chen et al.

Summary: This study investigated the mechanism of baicalein in Parkinson's disease, revealing that baicalein mediates mitochondrial autophagy and restores neuronal activity by downregulating miR-30b and activating the NIX/BNIP3 pathway.

BIOCHEMISTRY RESEARCH INTERNATIONAL (2021)

Article Neurosciences

DNA Double-Strand Break Accumulation in Alzheimer's Disease: Evidence from Experimental Models and Postmortem Human Brains

Nidheesh Thadathil et al.

Summary: Alzheimer's disease (AD) is characterized by progressive neurodegeneration with accumulation of DNA double-strand breaks (DSBs) playing an important role in its pathogenesis. Studies have shown increased DNA DSB accumulation and reduced repair function in the hippocampus of AD brains compared to non-AD brains. Additionally, altered levels of DNA repair proteins were observed in AD mouse models and cellular models, highlighting the potential influence of DNA DSB and repair proteins in the pathway toward neural damage and memory loss in AD.

MOLECULAR NEUROBIOLOGY (2021)

Review Cell Biology

Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review

Danko Jeremic et al.

Summary: Alzheimer's disease is the most common neurodegenerative disease in aging population with lack of effective treatments. Accumulation of Aβ peptides is considered one of the fundamental neuropathological pillars of the disease, thus many therapies target Aβ.

AGEING RESEARCH REVIEWS (2021)

Review Biochemistry & Molecular Biology

The emerging potential of SIRT-3 in oxidative stress-inflammatory axis associated increased neuroinflammatory component for metabolically impaired neural cell

Waleed Hassan Almalki et al.

Summary: This study investigates the mechanisms of inflammation related to neurodegenerative disorders, as well as the association between neuronal inflammation and metabolic disorders. It explores the potential role of SIRT-3 in regulating neuroinflammatory components.

CHEMICO-BIOLOGICAL INTERACTIONS (2021)

Article Neurosciences

Intranasal insulin improves mitochondrial function and attenuates motor deficits in a rat 6-OHDA model of Parkinson's disease

Farideh Iravanpour et al.

Summary: The study investigated the effects of intranasal insulin treatment in a rat model of Parkinson's disease, showing significant improvements in motor dysfunction and dopaminergic cell death associated with the disease. The findings suggest that intranasal insulin may be a promising therapeutic approach for Parkinson's disease, potentially targeting mitochondrial dysfunction and modulating inflammation in the brain.

CNS NEUROSCIENCE & THERAPEUTICS (2021)

Article Neurosciences

Partial Inhibition of Mitochondrial Complex I Reduces Tau Pathology and Improves Energy Homeostasis and Synaptic Function in 3xTg-AD Mice

Andrea Stojakovic et al.

Summary: Treatment with CP2 can improve cognitive function, synaptic protein levels, glucose metabolism, and energy homeostasis in 3xTg-AD mice, especially restoring synaptic activity in female mice. This suggests that targeting mitochondria with specific MCI inhibitors could be a promising strategy for treating Alzheimer's disease.

JOURNAL OF ALZHEIMERS DISEASE (2021)

Article Biochemistry & Molecular Biology

Variability of mitochondrial energy balance across brain regions

XinPing Cheng et al.

Summary: Neurons from different brain regions exhibit varying vulnerabilities to mitochondrial mutations and toxins, potentially due to differences in energy metabolism. Specifically, midbrain neurons and astrocytes have a higher metabolic rate and ATP consumption, making them more susceptible to energy deprivation.

JOURNAL OF NEUROCHEMISTRY (2021)

Article Neurosciences

Ursodeoxycholic acid protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis in MPTP/MPP+-induced Parkinson's disease

Huiping Qi et al.

Summary: Neuroprotection targeting mitochondrial dysfunction with ursodeoxycholic acid (UDCA) shows potential therapeutic effects for Parkinson's disease (PD). UDCA improves motor dysfunction, protects dopaminergic neurons, and regulates autophagy and apoptosis through activating the AMPK/mTOR and PINK1/Parkin pathways. The study suggests that UDCA may have pharmacological benefits in treating PD by modulating mitochondrial function.

NEUROSCIENCE LETTERS (2021)

Article Biology

Partial inhibition of mitochondrial complex I ameliorates Alzheimer's disease pathology and cognition in APP/PS1 female mice

Andrea Stojakovic et al.

Summary: Partial inhibition of mitochondrial complex I can reduce neurodegeneration and improve key disease phenotypes in a symptomatic mouse model of Alzheimer's disease, including enhancing cognitive function and reducing oxidative stress and inflammation.

COMMUNICATIONS BIOLOGY (2021)

Article Biochemistry & Molecular Biology

Mitochondrial SIRT3 confers neuroprotection in Huntington's disease by regulation of oxidative challenges and mitochondrial dynamics

Luana Naia et al.

Summary: The study demonstrates that SIRT3 plays a neuroprotective role in Huntington's disease by regulating oxidative stress and mitochondrial function, suggesting a potential therapeutic target for the disease.

FREE RADICAL BIOLOGY AND MEDICINE (2021)

Review Geriatrics & Gerontology

Emerging roles of oxidative stress in brain aging and Alzheimer's disease

Andra Ionescu-Tucker et al.

Summary: Reactive oxygen species (ROS) are metabolic byproducts that can be toxic at high levels and have been linked to cognitive aging and neurodegenerative diseases. Therapeutics like antioxidants, caloric restriction, and physical activity can reduce oxidation and prevent cognitive decline in brain aging and AD. Long term physical activity shows promise in improving cognitive health by reducing ROS levels and promoting optimal function.

NEUROBIOLOGY OF AGING (2021)

Editorial Material Chemistry, Medicinal

Neurodegenerative disorders-Searching for targets and new ways of diseases treatment

Andrey Y. Abramov et al.

MEDICINAL RESEARCH REVIEWS (2021)

Article Multidisciplinary Sciences

Nuclear sensing of breaks in mitochondrial DNA enhances immune surveillance

Marco Tigano et al.

Summary: The study reveals that mtDSBs activate a type-I interferon response, leading to the phosphorylation of STAT1 and activation of interferon-stimulated genes. After breaks in mtDNA, herniation mediated by BAX and BAK releases mitochondrial RNA into the cytoplasm and triggers a RIG-I-MAVS-dependent immune response.

NATURE (2021)

Review Neurosciences

Mitochondrial Quality Control Strategies: Potential Therapeutic Targets for Neurodegenerative Diseases?

Di Hu et al.

Summary: The maintenance of mitochondrial quality control is essential for the treatment of neurodegenerative diseases, as it plays a crucial role in preserving mitochondrial integrity and homeostasis to prevent disease progression. Mitochondrial dysfunction is an early factor in disease pathogenesis, and genetic or pharmaceutical interventions can restore mitochondrial integrity and ameliorate disease progression.

FRONTIERS IN NEUROSCIENCE (2021)

Article Biochemistry & Molecular Biology

Selective serotonin reuptake inhibitor citalopram ameliorates cognitive decline and protects against amyloid beta-induced mitochondrial dynamics, biogenesis, autophagy, mitophagy and synaptic toxicities in a mouse model of Alzheimer's disease

Arubala P. Reddy et al.

Summary: The study investigates the protective role of citalopram against cognitive decline, impaired mitochondrial dynamics, and synaptic dysfunction in an Alzheimer's disease mouse model. Citalopram treatment improved cognitive behavior, reduced Aβ levels, and decreased mitochondrial and synaptic toxicities in the treated mice compared to the untreated mice. The findings suggest that citalopram may have a strong protective effect against injuries induced by mutant APP and Aβ in depression, anxiety, and AD patients.

HUMAN MOLECULAR GENETICS (2021)

Article Biochemistry & Molecular Biology

Mitochondrial dysfunction as a driver of NLRP3 inflammasome activation and its modulation through mitophagy for potential therapeutics

Soumya Ranjan Mishra et al.

Summary: The NLRP3 inflammasome plays a crucial role in neuroinflammation and neural diseases. Dysfunctional mitochondria and accumulation of mitochondrial reactive oxygen species are key factors in the activation of NLRP3 inflammasome.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2021)

Review Biochemistry & Molecular Biology

Alzheimer's Disease Pathogenesis: Role of Autophagy and Mitophagy Focusing in Microglia

Mehdi Eshraghi et al.

Summary: Alzheimer's disease is a debilitating neurological disorder with no current cure. Pathological features such as amyloid plaques and tau tangles are characteristic of AD, but targeting these has not shown desired efficacy in patients. Autophagy, inflammation, and microglia play significant roles in AD pathogenesis and may provide potential therapeutic targets.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

Neuroprotective Activity of Melittin-The Main Component of Bee Venom-Against Oxidative Stress Induced by Aβ25-35 in In Vitro and In Vivo Models

Cong Duc Nguyen et al.

Summary: Melittin, the main component of honeybee venom, has been found to exhibit neuroprotective actions by alleviating oxidative stress and memory impairment in both in vitro and in vivo models. It effectively protects neuronal cells by regulating reactive oxygen species and apoptosis-related factors, while enhancing antioxidant defense pathways. Melittin also activates neurogenesis pathways and improves cognitive deficits, suggesting its potential as a therapeutic agent for neurodegenerative disorders.

ANTIOXIDANTS (2021)

Article Biochemistry & Molecular Biology

An Unrecognized Fundamental Relationship between Neurotransmitters: Glutamate Protects against Catecholamine Oxidation

Wenping Wang et al.

Summary: This study demonstrates that glutamate can effectively inhibit the oxidation of catecholamines and the associated formation of hydroxyl radicals, quinoproteins, and DNA damage. The protective mechanism of glutamate against catecholamine oxidation is attributed to its chelation of copper, restricting its redox activity.

ANTIOXIDANTS (2021)

Article Biology

Inflammatory Response Modulation by Vitamin C in an MPTP Mouse Model of Parkinson's Disease

Francesco De Nuccio et al.

Summary: Vitamin C plays a crucial role in preventing and alleviating inflammation, particularly in neurodegenerative diseases like Parkinson's disease. Research indicates that Vitamin C can reduce neuroinflammation, protect the brain, and slow down the progression of Parkinson's disease.

BIOLOGY-BASEL (2021)

Article Neurosciences

Anti-inflammatory and neuroprotective effects of natural cordycepin in rotenone-induced PD models through inhibiting Drp1-mediated mitochondrial fission

Xiao-Ling Zhang et al.

Summary: Cordycepin has been shown to ameliorate motor dysfunction and dopaminergic neurons loss induced by rotenone exposure, maintain normal mitochondrial morphology, increase ATP content and MMP, and reduce mitochondrial ROS levels and complex 1 activity. Additionally, cordycepin effectively inhibits the expression of NLRP3 inflammasome components and the release of pro-inflammatory cytokines. The study also demonstrates that NLRP3 inflammasome activation within neurons can be suppressed by the mitochondrial division inhibitor Mdivi-1.

NEUROTOXICOLOGY (2021)

Article Multidisciplinary Sciences

Intranasal delivery of mitochondria for treatment of Parkinson's Disease model rats lesioned with 6-hydroxydopamine

Jui-Chih Chang et al.

Summary: In this study, intranasal delivery of mitochondria showed promise in improving rotational and locomotor behaviors, promoting survival and recovery of DA neurons, and attenuating oxidative damage in 6-OHDA-lesioned rats with Parkinson's disease. The conjugation of mitochondria with Pep-1 appeared to have a stronger therapeutic effect compared to unconjugated mitochondria.

SCIENTIFIC REPORTS (2021)

Article Biochemistry & Molecular Biology

Kaempferol alleviates LD-mitochondrial damage by promoting autophagy: Implications in Parkinson?s disease

Xiaojuan Han et al.

Summary: The study demonstrates that kaempferol prevents dopaminergic neuronal degeneration in Parkinson's disease by inhibiting lipid peroxidation-mediated mitochondrial damage through promoting lipophagy, providing a potential novel therapeutic strategy for Parkinson's disease and related neurodegenerative diseases.

REDOX BIOLOGY (2021)

Review Biochemistry & Molecular Biology

Alpha-Synuclein and Mitochondrial Dysfunction in Parkinson's Disease: The Emerging Role of VDAC

Pierpaolo Risiglione et al.

Summary: The function of alpha-Synuclein, its interaction with VDAC, and its involvement in pathological processes are the main focus of current research on mitochondrial function modulation.

BIOMOLECULES (2021)

Article Biochemistry & Molecular Biology

Dual Inhibitors of Amyloid-β and Tau Aggregation with Amyloid-β Disaggregating Properties: Extended In Cellulo, In Silico, and Kinetic Studies of Multifunctional Anti-Alzheimer's Agents

Anna Pasieka et al.

Summary: The study identified a potent dual aggregation inhibitor for Alzheimer's disease, with compound 18 showing the most balanced and strong inhibitory effects on amyloid beta and tau aggregation. This compound also exhibited inhibitory activity against hBuChE, hBACE1, and A beta, and may provide insight into the design of future generations of aggregation inhibitors.

ACS CHEMICAL NEUROSCIENCE (2021)

Review Medicine, Research & Experimental

Advances in developing therapeutic strategies for Alzheimer's disease

Thuy Trang Nguyen et al.

Summary: Alzheimer's disease is a progressive deterioration of brain function, with current treatment options unable to cure the disease. Nanoparticles offer a promising approach to overcome the challenges of blood-brain interfaces and deliver drugs more effectively to the brain.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Review Environmental Sciences

Connecting the dots between mitochondrial dysfunction and Parkinson's disorder: focus mitochondria-targeting therapeutic paradigm in mitigating the disease severity

Ishnoor Kaur et al.

Summary: Mitochondria play multifactorial roles in cellular processes, particularly in neural and dopaminergic neurons where dysfunction can lead to various neurological disorders such as Parkinson's disease. Modulation of mitochondrial homeostasis regulating genes potentiates the pathophysiology of PD, highlighting the central role of unhealthy mitochondria in neurodegeneration and emphasizing potential therapeutic targets for the disease.

ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2021)

Article Pharmacology & Pharmacy

Mitochondrial dysfunction and apoptosis are attenuated through activation of AMPK/GSK-3β/PP2A pathway in Parkinson's disease

Jianhua Su et al.

Summary: Parkinson's disease is a common neurological disorder characterized by loss of dopaminergic neurons and decreased dopamine content. Mitochondrial dysfunction and apoptosis may play a role in the pathogenesis of PD, potentially mediated by the AMPK/GSK-3 beta/PP2A pathway.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

Review Biochemistry & Molecular Biology

Glucose Metabolic Dysfunction in Neurodegenerative Diseases-New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming

Rongrong Han et al.

Summary: Glucose is the main energy substrate for the adult brain and plays a crucial role in neuronal function. Dysregulation of glucose metabolism is commonly observed in neurodegenerative diseases, highlighting the importance of understanding metabolic adaptation mechanisms and potential interventions. Mitochondrial dysfunction, decreased glucose uptake, and hypoxia are key factors in neurodegeneration and may serve as targets for therapeutic strategies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemistry & Molecular Biology

Insulin and Insulin Resistance in Alzheimer's Disease

Aleksandra Sedzikowska et al.

Summary: Insulin plays multiple roles in the central nervous system, including regulating glucose metabolism, supporting cognition, enhancing neuron outgrowth, etc. Changes in insulin signaling may lead to adverse consequences, such as accelerating brain aging and affecting neuronal plasticity.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Neurosciences

Dysfunction of X-linked inhibitor of apoptosis protein (XIAP) triggers neuropathological processes via altered p53 activity in Huntington's disease

Seung Jae Hyeon et al.

Summary: Mitochondrial dysfunction in Huntington's disease is associated with a decrease in XIAP-p53 colocalization and a reduction in XIAP levels due to mutant Huntingtin overexpression, leading to mitochondrial localization of p53. XIAP interacts with p53 C-terminal domain and decreases its stability via autophagy, preventing mitochondrial oxidative stress and cell death. Dysregulation of XIAP triggers mitochondrial dysfunction and neuropathological processes, while XIAP overexpression improves neuropathology in mouse models of HD.

PROGRESS IN NEUROBIOLOGY (2021)

Article Multidisciplinary Sciences

Small-molecule suppression of calpastatin degradation reduces neuropathology in models of Huntington's disease

Di Hu et al.

Summary: The authors identified CHIR99021 as a potent enhancer of mitochondrial function, improving mitochondrial phenotypes in Huntington's disease models. CHIR99021 stabilized calpastatin to suppress calpain activation and Drp1-induced mitochondrial fragmentation, offering a potential therapeutic strategy for neurological disorders characterized by mitochondrial dysfunction.

NATURE COMMUNICATIONS (2021)

Review Neurosciences

Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms

Zenghui Wei et al.

Summary: Alzheimer's disease is a chronic neurodegenerative disease that accounts for a majority of dementia cases and is one of the leading causes of death in the United States. Insulin resistance has been shown to play a significant role in the development of AD, with over 80% of patients also having type II diabetes, suggesting overlapping pathogenic mechanisms. Insulin resistance increases neuroinflammation, leading to amyloid beta-protein deposition and aberrant tau phosphorylation, ultimately contributing to the progression of AD.

FRONTIERS IN NEUROSCIENCE (2021)

Article Biochemistry & Molecular Biology

Targeted Ablation of Primary Cilia in Differentiated Dopaminergic Neurons Reduces Striatal Dopamine and Responsiveness to Metabolic Stress

Rasem Mustafa et al.

Summary: Primary cilia play a crucial role in maintaining vulnerable dopaminergic neurons in Parkinson's disease, regulating their spontaneous activity and susceptibility to neurotoxic substances. These findings highlight the significance of primary cilia in dopamine system disorders and stress responses.

ANTIOXIDANTS (2021)

Article Biochemistry & Molecular Biology

Key Mechanisms and Potential Implications of Hericium erinaceus in NLRP3 Inflammasome Activation by Reactive Oxygen Species during Alzheimer's Disease

Marika Cordaro et al.

Summary: Alzheimer's disease is the principal cause of dementia and is associated with neurodegenerative disorders. Hericium erinaceus, a nutritional mushroom with important antioxidant effects, has shown significant therapeutic effects in a rat model of AD, reducing behavioral changes and hippocampal neuronal degeneration.

ANTIOXIDANTS (2021)

Article Clinical Neurology

Neuroprotective Effect of Fucoxanthin against Intracerebroventricular Streptozotocin (ICV-STZ) Induced Cognitive Impairment in Experimental Rats

Mahadev Dhami et al.

Summary: The study demonstrated that fucoxanthin may be a promising compound for improving cognitive functions through antioxidant, anti-inflammatory, and neuroprotective mechanisms, as well as inhibition of acetylcholinesterase (AChE) enzyme activities, A beta((1-42)) accumulation, and tau protein.

CURRENT ALZHEIMER RESEARCH (2021)

Article Cell Biology

Mitochondrial fission and fusion: A dynamic role in aging and potential target for age-related disease

Yasmine J. Liu et al.

MECHANISMS OF AGEING AND DEVELOPMENT (2020)

Article Neurosciences

Neuroprotective Effects of Doxycycline in the R6/2 Mouse Model of Huntington's Disease

Emanuela Paldino et al.

MOLECULAR NEUROBIOLOGY (2020)

Review Neurosciences

Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances

Wenzhang Wang et al.

MOLECULAR NEURODEGENERATION (2020)

Review Cell Biology

Mitophagy: An Emerging Role in Aging and Age-Associated Diseases

Guo Chen et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Review Neurosciences

Development of early diagnosis of Parkinson's disease: Illusion or reality?

Michael Ugrumov

CNS NEUROSCIENCE & THERAPEUTICS (2020)

Review Immunology

The role of innate immunity in Alzheimer's disease

Hannah E. Ennerfelt et al.

IMMUNOLOGICAL REVIEWS (2020)

Review Biotechnology & Applied Microbiology

Multitarget Therapeutic Strategies for Alzheimer's Disease: Review on Emerging Target Combinations

Samuele Maramai et al.

BIOMED RESEARCH INTERNATIONAL (2020)

Article Biochemistry & Molecular Biology

SkQ1 Suppresses the p38 MAPK Signaling Pathway Involved in Alzheimer's Disease-Like Pathology in OXYS Rats

Natalia A. Muraleva et al.

ANTIOXIDANTS (2020)

Review Biotechnology & Applied Microbiology

Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing

Stephen C. Cunnane et al.

NATURE REVIEWS DRUG DISCOVERY (2020)

Review Geriatrics & Gerontology

Mitochondrial Dysfunction and Alzheimer's Disease: Role of Microglia

Ishan Agrawal et al.

FRONTIERS IN AGING NEUROSCIENCE (2020)

Review Cell Biology

Defective mitophagy in Alzheimer's disease

Jangampalli Adi Pradeepkiran et al.

AGEING RESEARCH REVIEWS (2020)

Review Biochemistry & Molecular Biology

Peripheral Glycolysis in Neurodegenerative Diseases

Simon M. Bell et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Chemistry, Multidisciplinary

Targeting Microglia for Therapy of Parkinson's Disease by Using Biomimetic Ultrasmall Nanoparticles

Hanghang Liu et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)

Review Neurosciences

A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity

Hossam Kadry et al.

FLUIDS AND BARRIERS OF THE CNS (2020)

Review Neurosciences

Tau and DNA Damage in Neurodegeneration

Luca Colnaghi et al.

BRAIN SCIENCES (2020)

Review Cell & Tissue Engineering

Mitochondrial dysfunction in neurological disorders: Exploring mitochondrial transplantation

Pedro Norat et al.

NPJ REGENERATIVE MEDICINE (2020)

Article Neurosciences

LRRK2 and mitochondria: Recent advances and current views

Alpana Singh et al.

BRAIN RESEARCH (2019)

Review Neurosciences

Molecular Basis of Alzheimer's Disease: Focus on Mitochondria

Darryll M. A. Oliver et al.

JOURNAL OF ALZHEIMERS DISEASE (2019)

Review Cell Biology

Microglia in Alzheimer's disease: A target for immunotherapy

Shoutang Wang et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2019)

Article Immunology

Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice

Zhuo Gong et al.

JOURNAL OF NEUROINFLAMMATION (2019)

Article Neurosciences

Mitochondrial Dysfunction in Huntington's Disease; Interplay Between HSF1, p53 and PGC-1α Transcription Factors

Taylor A. Intihar et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2019)

Article Pharmacology & Pharmacy

Shortage of Cellular ATP as a Cause of Diseases and Strategies to Enhance ATP

Todd A. Johnson et al.

FRONTIERS IN PHARMACOLOGY (2019)

Article Biochemistry & Molecular Biology

Small Molecule Inhibits Metal-Dependent and -Independent Multifaceted Toxicity of Alzheimer's Disease

Sourav Samanta et al.

ACS CHEMICAL NEUROSCIENCE (2019)

Article Neurosciences

Early neuronal accumulation of DNA double strand breaks in Alzheimer's disease

Niraj M. Shanbhag et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)

Review Neurosciences

Emerging Perspectives on DNA Double-strand Breaks in Neurodegenerative Diseases

Ling-Shuang Zhu et al.

CURRENT NEUROPHARMACOLOGY (2019)

Article Neurosciences

Mitochondria' dynamics and transport in Alzheimer's disease

Padraig J. Flannery et al.

MOLECULAR AND CELLULAR NEUROSCIENCE (2019)

Article Clinical Neurology

Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives

Chiara Lanzillotta et al.

CNS DRUGS (2019)

Review Pharmacology & Pharmacy

Mitochondria as Potential Targets in Alzheimer Disease Therapy: An Update

Giovanna Cenini et al.

FRONTIERS IN PHARMACOLOGY (2019)

Article Biochemistry & Molecular Biology

Microglial mitophagy mitigates neuroinflammation in Alzheimer's disease

Sofie Lautrup et al.

NEUROCHEMISTRY INTERNATIONAL (2019)

Article Multidisciplinary Sciences

N,N'-Diacetyl-p-phenylenediamine restores microglial phagocytosis and improves cognitive defects in Alzheimer's disease transgenic mice

Min Hee Park et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Biochemistry & Molecular Biology

The RNA-Binding Protein PUM2 Impairs Mitochondrial Dynamics and Mitophagy During Aging

Davide D'Amico et al.

MOLECULAR CELL (2019)

Editorial Material Neurosciences

Editorial: Mitochondrial Dysfunction and Neurodegeneration

Victor Tapias

FRONTIERS IN NEUROSCIENCE (2019)

Review Cell Biology

Multitarget therapeutic strategies for Alzheimer's disease

Mostafa M. Ibrahim et al.

NEURAL REGENERATION RESEARCH (2019)

Article Biochemistry & Molecular Biology

HACE1 is essential for astrocyte mitochondrial function and influences Huntington disease phenotypes in vivo

Dagmar E. Ehrnhoefer et al.

HUMAN MOLECULAR GENETICS (2018)

Review Cell Biology

Microglia in Alzheimer's disease

David V. Hansen et al.

JOURNAL OF CELL BIOLOGY (2018)

Article Cell Biology

Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases

Michael G. Erkkinen et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)

Article Biochemistry & Molecular Biology

Hybrid Multifunctional Modulators Inhibit Multifaceted Aβ Toxicity and Prevent Mitochondrial Damage

K. Rajasekhar et al.

ACS CHEMICAL NEUROSCIENCE (2018)

Article Biochemistry & Molecular Biology

Resveratrol prolongs lifespan and improves 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced oxidative damage and behavioural deficits in Drosophila melanogaster

Amos O. Abolaji et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

Article Biochemistry & Molecular Biology

MitoQ protects dopaminergic neurons in a 6-OHDA induced PD model by enhancing Mfn2-dependent mitochondrial fusion via activation of PGC-1α

Ye Xi et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)

Article Cell Biology

Basal Mitophagy Occurs Independently of PINK1 in Mouse Tissues of High Metabolic Demand

Thomas G. McWilliams et al.

CELL METABOLISM (2018)

Article Biochemistry & Molecular Biology

Oxidative stress and neurodegeneration: The possible contribution of quinone reductase 2

Laure-Estelle Cassagnes et al.

FREE RADICAL BIOLOGY AND MEDICINE (2018)

Review Neurosciences

Mitochondria and Mitochondrial Cascades in Alzheimer's Disease

Russell H. Swerdlow

JOURNAL OF ALZHEIMERS DISEASE (2018)

Review Clinical Neurology

The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders

Susana Carmona et al.

LANCET NEUROLOGY (2018)

Article Neurosciences

Perturbations in the p53/miR-34a/SIRT1 pathway in the R6/2 Huntington's disease model

Regina Hertfelder Reynolds et al.

MOLECULAR AND CELLULAR NEUROSCIENCE (2018)

Review Clinical Neurology

Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

Melanie D. Sweeney et al.

NATURE REVIEWS NEUROLOGY (2018)

Article Clinical Neurology

The 200-year journey of Parkinson disease: Reflecting on the past and looking towards the future

Stanley Fahn

PARKINSONISM & RELATED DISORDERS (2018)

Article Neurosciences

Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease

Bahareh Eftekharzadeh et al.

NEURON (2018)

Review Biochemistry & Molecular Biology

The Role of Mitochondrial Dysfunction in the Progression of Alzheimer's Disease

Claus Desler et al.

CURRENT MEDICINAL CHEMISTRY (2018)

Review Neurosciences

Advances in developing novel therapeutic strategies for Alzheimer's disease

Jiqing Cao et al.

MOLECULAR NEURODEGENERATION (2018)

Review Geriatrics & Gerontology

TREM2 in Alzheimer's Disease: Microglial Survival and Energy Metabolism

Honghua Zheng et al.

FRONTIERS IN AGING NEUROSCIENCE (2018)

Article Geriatrics & Gerontology

A Critical Role of Autophagy in Regulating Microglia Polarization in Neurodegeneration

Meng-meng Jin et al.

FRONTIERS IN AGING NEUROSCIENCE (2018)

Article Biochemistry & Molecular Biology

Mitochondria-targeted small molecule SS31: a potential candidate for the treatment of Alzheimer's disease

P. Hemachandra Reddy et al.

HUMAN MOLECULAR GENETICS (2017)

Article Biochemistry & Molecular Biology

Inhibition of mitochondrial fragmentation protects against Alzheimer's disease in rodent model

Wenzhang Wang et al.

HUMAN MOLECULAR GENETICS (2017)

Article Clinical Neurology

Epidemiology of Parkinson's disease

Ole-Bjorn Tysnes et al.

JOURNAL OF NEURAL TRANSMISSION (2017)

Article Immunology

Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease

Charbel Moussa et al.

JOURNAL OF NEUROINFLAMMATION (2017)

Article Neurosciences

The PINK1 p.I368N mutation affects protein stability and ubiquitin kinase activity

Maya Ando et al.

MOLECULAR NEURODEGENERATION (2017)

Article Multidisciplinary Sciences

Structure of PINK1 in complex with its substrate ubiquitin

Alexander F. Schubert et al.

NATURE (2017)

Article Multidisciplinary Sciences

Enhancing mitochondrial proteostasis reduces amyloid-β proteotoxicity

Vincenzo Sorrentino et al.

NATURE (2017)

Article Multidisciplinary Sciences

Polyglutamine tracts regulate beclin 1-dependent autophagy

Avraham Ashkenazi et al.

NATURE (2017)

Article Biochemistry & Molecular Biology

Mitochondrial respiratory chain disorganization in Parkinson's disease-relevant PINK1 and DJ1 mutants

Irene Lopez-Fabuel et al.

NEUROCHEMISTRY INTERNATIONAL (2017)

Article Multidisciplinary Sciences

KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington's disease patients

Luisa Quinti et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Multidisciplinary Sciences

Neuron-specific methylome analysis reveals epigenetic regulation and tau-related dysfunction of BRCA1 in Alzheimer's disease

Tatsuo Mano et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Review Neurosciences

Mitophagy and Alzheimer's Disease: Cellular and Molecular Mechanisms

Jesse S. Kerr et al.

TRENDS IN NEUROSCIENCES (2017)

Article Multidisciplinary Sciences

A role for Tau protein in maintaining ribosomal DNA stability and cytidine deaminase-deficient cell survival

Elias Bou Samra et al.

NATURE COMMUNICATIONS (2017)

Article Multidisciplinary Sciences

A synthetic cell permeable antioxidant protects neurons against acute oxidative stress

Nicola J. Drummond et al.

SCIENTIFIC REPORTS (2017)

Article Cell Biology

The Self-Inactivating KamiCas9 System for the Editing of CNS Disease Genes

Nicolas Merienne et al.

CELL REPORTS (2017)

Article Geriatrics & Gerontology

DJ-1 Inhibits α-Synuclein Aggregation by Regulating Chaperone-Mediated Autophagy

Chuan-Ying Xu et al.

FRONTIERS IN AGING NEUROSCIENCE (2017)

Article Neurosciences

Phase IIb Study of Intranasal Glutathione in Parkinson's Disease

Laurie K. Mischley et al.

JOURNAL OF PARKINSONS DISEASE (2017)

Article Neurosciences

Oxidative Stress Modifies the Levels and Phosphorylation State of Tau Protein in Human Fibroblasts

Alejandro Ibanez-Salazar et al.

FRONTIERS IN NEUROSCIENCE (2017)

Article Biochemistry & Molecular Biology

Trehalose Alters Subcellular Trafficking and the Metabolism of the Alzheimer-associated Amyloid Precursor Protein

Nguyen T. Tien et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2016)

Review Cell Biology

Metabolic regulation of mitochondrial dynamics

Prashant Mishra et al.

JOURNAL OF CELL BIOLOGY (2016)

Review Biochemistry & Molecular Biology

Mitochondrial dysfunction in Parkinson's disease

Anindita Bose et al.

JOURNAL OF NEUROCHEMISTRY (2016)

Review Biochemistry & Molecular Biology

The Mitochondrial Basis of Aging

Nuo Sun et al.

MOLECULAR CELL (2016)

Article Multidisciplinary Sciences

Synchronized mitochondrial and cytosolic translation programs

Mary T. Couvillion et al.

NATURE (2016)

Article Multidisciplinary Sciences

Mito-priming as a method to engineer Bcl-2 addiction

Jonathan Lopez et al.

NATURE COMMUNICATIONS (2016)

Article Multidisciplinary Sciences

Resveratrol induces autophagy by directly inhibiting mTOR through ATP competition

Dohyun Park et al.

SCIENTIFIC REPORTS (2016)

Review Medicine, Research & Experimental

Role of oxidative stress in Alzheimer's disease

Wen-Juan Huang et al.

BIOMEDICAL REPORTS (2016)

Review Neurosciences

Oxidative Stress and Huntington's Disease: The Good, The Bad, and The Ugly

Amit Kumar et al.

JOURNAL OF HUNTINGTONS DISEASE (2016)

Article Medicine, Research & Experimental

Impaired GAPDH-induced mitophagy contributes to the pathology of Huntington's disease

Sunhee Hwang et al.

EMBO MOLECULAR MEDICINE (2015)

Article Biochemistry & Molecular Biology

Oxidative metabolism in YAC128 mouse model of Huntington's disease

James Hamilton et al.

HUMAN MOLECULAR GENETICS (2015)

Review Cell Biology

Systems biology of neurodegenerative diseases

Levi B. Wood et al.

INTEGRATIVE BIOLOGY (2015)

Article Clinical Neurology

Abnormalities in the Tricarboxylic Acid Cycle in Huntington Disease and in a Huntington Disease Mouse Model

Nima N. Naseri et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2015)

Review Biochemistry & Molecular Biology

Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease

Brent J. Ryan et al.

TRENDS IN BIOCHEMICAL SCIENCES (2015)

Article Cell Biology

The Blood-Brain Barrier

Richard Daneman et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2015)

Article Cell Biology

PINK1-induced mitophagy promotes neuroprotection in Huntington's disease

B. Khalil et al.

CELL DEATH & DISEASE (2015)

Review Anatomy & Morphology

Oxidative stress and Parkinson's disease

Javier Blesa et al.

FRONTIERS IN NEUROANATOMY (2015)

Review Medicine, Research & Experimental

Mitochondrial Dysfunction in Parkinson's Disease

Hyo Eun Moon et al.

EXPERIMENTAL NEUROBIOLOGY (2015)

Review Medicine, Research & Experimental

The Role of Oxidative Stress in Neurodegenerative Diseases

Geon Ha Kim et al.

EXPERIMENTAL NEUROBIOLOGY (2015)

Article Biochemistry & Molecular Biology

DNA polymerase β deficiency leads to neurodegeneration and exacerbates Alzheimer disease phenotypes

Peter Sykora et al.

NUCLEIC ACIDS RESEARCH (2015)

Review Biochemistry & Molecular Biology

Molecular diagnostics of neurodegenerative disorders

Megha Agrawal et al.

FRONTIERS IN MOLECULAR BIOSCIENCES (2015)

Article Biochemistry & Molecular Biology

Does High-Dose Coenzyme Q10 Improve Oxidative Damage and Clinical Outcomes in Parkinson's Disease?

Raymond Chee-Seong Seet et al.

ANTIOXIDANTS & REDOX SIGNALING (2014)

Review Pharmacology & Pharmacy

Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers

Christiane Reitz et al.

BIOCHEMICAL PHARMACOLOGY (2014)

Review Biochemistry & Molecular Biology

Oxidative stress and mitochondrial dysfunction in Alzheimer's disease

Xinglong Wang et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)

Review Clinical Neurology

Type 3 diabetes is sporadic Alzheimer's disease: Mini-review

Suzanne M. de la Monte

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)

Article Geriatrics & Gerontology

Coenzyme Q10 and α-tocopherol reversed age-associated functional impairments in mice

Ritu A. Shetty et al.

EXPERIMENTAL GERONTOLOGY (2014)

Review Neurosciences

Apoptosis and Oxidative Stress in Neurodegenerative Diseases

Elena Radi et al.

JOURNAL OF ALZHEIMERS DISEASE (2014)

Article Neurosciences

Inhibition of mitochondrial protein import by mutant huntingtin

Hiroko Yano et al.

NATURE NEUROSCIENCE (2014)

Editorial Material Clinical Neurology

THE GLOBAL BURDEN OF NEUROLOGIC DISEASES

Jerome H. Chin et al.

NEUROLOGY (2014)

Review Biotechnology & Applied Microbiology

Mitochondrial Dysfunctions in Neurodegenerative Diseases: Relevance to Alzheimer's Disease

Jana Hroudova et al.

BIOMED RESEARCH INTERNATIONAL (2014)

Editorial Material Cell Biology

Early detection of neurodegenerative diseases Circulating brain-enriched microRNA

Kira S. Sheinerman et al.

CELL CYCLE (2013)

Review Chemistry, Medicinal

The Multifactorial Nature of Alzheimer's Disease for Developing Potential Therapeutics

M. Carmo Carreiras et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)

Review Geriatrics & Gerontology

Adherence to Cholinesterase Inhibitors in Alzheimer's Disease: A Review

Roseanna Brady et al.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2013)

Article Medicine, Research & Experimental

Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration

Xing Guo et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Article Biochemistry & Molecular Biology

Mitochondrial dynamics modulate the expression of pro-inflammatory mediators in microglial cells

Junghyung Park et al.

JOURNAL OF NEUROCHEMISTRY (2013)

Review Clinical Neurology

Developing Therapeutic Antibodies for Neurodegenerative Disease

Y. Joy Yu et al.

NEUROTHERAPEUTICS (2013)

Review Cell Biology

Deconstructing Mitochondrial Dysfunction in Alzheimer Disease

Vega Garcia-Escudero et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)

Review Cell Biology

Oxidative Stress and the Pathogenesis of Alzheimer's Disease

Yan Zhao et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)

Article Cell Biology

Mechanisms of Mitochondrial Fission and Fusion

Alexander M. van der Bliek et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)

Review Neurosciences

The Role of Oxidative Stress in Parkinson's Disease

Vera Dias et al.

JOURNAL OF PARKINSONS DISEASE (2013)

Review Biochemistry & Molecular Biology

Toxin Models of Mitochondrial Dysfunction in Parkinson's Disease

Terina N. Martinez et al.

ANTIOXIDANTS & REDOX SIGNALING (2012)

Article Biochemistry & Molecular Biology

Inhibition of Drp1 provides neuroprotection in vitro and in vivo

J. Grohm et al.

CELL DEATH AND DIFFERENTIATION (2012)

Article Clinical Neurology

Mitochondria, oxidative stress and neurodegeneration

Antonio Federico et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)

Review Cell Biology

Mechanism of Oxidative Stress in Neurodegeneration

Sonia Gandhi et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2012)

Article Medicine, Research & Experimental

Mitochondrial Biology and Parkinson's Disease

Celine Perier et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)

Review Biochemistry & Molecular Biology

Mitochondrial Dynamics in Diabetes

Yisang Yoon et al.

ANTIOXIDANTS & REDOX SIGNALING (2011)

Article Biochemistry & Molecular Biology

Mesencephalic Astrocyte-derived Neurotrophic Factor (MANF) Has a Unique Mechanism to Rescue Apoptotic Neurons

Maarit Hellman et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Review Cell Biology

Mechanisms of mitophagy

Richard J. Youle et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)

Review Cell Biology

Oxidative Stress in Neurodegenerative Diseases: Mechanisms and Therapeutic Perspectives

Ailton Melo et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2011)

Article Multidisciplinary Sciences

A Novel Neurotrophic Drug for Cognitive Enhancement and Alzheimer's Disease

Qi Chen et al.

PLOS ONE (2011)

Review Biochemistry & Molecular Biology

Mitochondrial dysfunction in Parkinson's disease

Konstanze F. Winklhofer et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)

Article Clinical Neurology

Tau in Alzheimer Disease and Related Tauopathies

K. Iqbal et al.

CURRENT ALZHEIMER RESEARCH (2010)

Article Geriatrics & Gerontology

Mitochondrial Dynamics in Alzheimer's Disease Opportunities for Future Treatment Strategies

David J. Bonda et al.

DRUGS & AGING (2010)

Review Biochemistry & Molecular Biology

The Cvt pathway as a model for selective autophagy

Melinda A. Lynch-Day et al.

FEBS LETTERS (2010)

Article Biochemistry & Molecular Biology

Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease

Jinho Kim et al.

HUMAN MOLECULAR GENETICS (2010)

Review Neurosciences

A Mitocentric View of Alzheimer's Disease Suggests Multi-Faceted Treatments

Gary E. Gibson et al.

JOURNAL OF ALZHEIMERS DISEASE (2010)

Review Cell Biology

Basic mechanisms of neurodegeneration: a critical update

Kurt A. Jellinger

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)

Review Neurosciences

Oxidative stress in Alzheimer disease: A possibility for prevention

David J. Bonda et al.

NEUROPHARMACOLOGY (2010)

Review Medicine, General & Internal

MECHANISMS OF DISEASE Alzheimer's Disease

Henry W. Querfurth et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Review Biochemistry & Molecular Biology

Role of mitochondrial dynamics proteins in the pathophysiology of obesity and type 2 diabetes

Antonio Zorzano et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)

Review Cell Biology

Mitochondrial accumulation of APP and A beta: significance for Alzheimer disease pathogenesis

Pavel F. Pavlov et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)

Article Neurosciences

Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease

Xinglong Wang et al.

JOURNAL OF NEUROSCIENCE (2009)

Article Biochemistry & Molecular Biology

PINK1-Associated Parkinson's Disease Is Caused by Neuronal Vulnerability to Calcium-induced Cell Death

Sonia Gandhi et al.

MOLECULAR CELL (2009)

Review Clinical Neurology

L-dopa therapy for Parkinson's disease: Past, present, and future

Toshiharu Nagatsu et al.

PARKINSONISM & RELATED DISORDERS (2009)

Article Multidisciplinary Sciences

Amyloid-β and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice

Virginie Rhein et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Review Biochemistry & Molecular Biology

Huntington's disease: degradation of mutant huntingtin by autophagy

Sovan Sarkar et al.

FEBS JOURNAL (2008)

Letter Pharmacology & Pharmacy

Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease

Larry Baum et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)

Review Chemistry, Medicinal

Multi-target-directed ligands to combat neurodegenerative diseases

Andrea Cavalli et al.

JOURNAL OF MEDICINAL CHEMISTRY (2008)

Review Clinical Neurology

Mitochondria in the aetiology and pathogenesis of Parkinson's disease

Anthony H. V. Schapira

LANCET NEUROLOGY (2008)

Review Cell Biology

Functions and dysfunctions of mitochondrial dynamics

Scott A. Detmer et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)

Review Cell Biology

Mitochondria and neuronal activity

Oliver Kann et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)

Review Biochemistry & Molecular Biology

Mitochondrial morphology and distribution in mammalian cells

Ann E. Frazier et al.

BIOLOGICAL CHEMISTRY (2006)

Review Multidisciplinary Sciences

Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases

Michael T. Lin et al.

NATURE (2006)

Article Clinical Neurology

Mitochondria take center stage in aging and neurodegeneration

MF Beal

ANNALS OF NEUROLOGY (2005)

Article Biochemistry & Molecular Biology

Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant Huntingtin

T Milakovic et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)

Article Biochemistry & Molecular Biology

Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L Tau transgenic mice

DC David et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)

Article Neurosciences

Tau protein is cross-linked by transglutaminase in P301L tau transgenic mice

RA Halverson et al.

JOURNAL OF NEUROSCIENCE (2005)

Review Biochemistry & Molecular Biology

Protein aggregation and neurodegenerative disease

CA Ross et al.

NATURE MEDICINE (2004)

Review Medicine, Research & Experimental

A mitochondrial cascade hypthesis for sporadic Alzheimer's disease

RH Swerdlow et al.

MEDICAL HYPOTHESES (2004)

Article Geriatrics & Gerontology

Cytochrome c oxidase is decreased in Alzheimer's disease platelets

SM Cardoso et al.

NEUROBIOLOGY OF AGING (2004)

Article Multidisciplinary Sciences

Hereditary early-onset Parkinson's disease caused by mutations in PINK1

EM Valente et al.

SCIENCE (2004)

Article Biochemistry & Molecular Biology

Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death

F Darios et al.

HUMAN MOLECULAR GENETICS (2003)

Article Neurosciences

Mitochondrial abnormalities in Alzheimer's disease

K Hirai et al.

JOURNAL OF NEUROSCIENCE (2001)